Scientists decode breast cancer DNA to unlock better treatments

NCT ID NCT02022202

First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study looked at the DNA of breast tumors from 140 patients to understand why some cancers are destroyed by standard chemotherapy and others are not. Researchers analyzed genetic changes in the tumors and compared them to normal DNA. The goal is to find new drug targets and improve future cancer therapies.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this research could point toward more personalized breast cancer treatments based on genetic mutations.

What could go wrong

This is an observational study, not a treatment trial. It may not directly lead to new therapies, and results may not apply to all breast cancer patients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INVASIVE BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

invasive breast carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Mayo Clinic

    Rochester, Minnesota, 55905, United States

  • Mayo Clinic campus in Arizona

    Scottsdale, Arizona, 85259, United States